Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy

被引:0
|
作者
S Vasu
H Wu
A Satoskar
M Puto
J Roddy
W Blum
R Klisovic
L Andritsos
C Hofmeister
D M Benson
Y Efebera
S Jaglowski
S Penza
D Cohen
S Devine
S Cataland
机构
[1] The Ohio State University,Division of Hematology
[2] The Ohio State University,Department of Pathology
[3] James Cancer Hospital,Department of Pharmacy
[4] The Ohio State University,undefined
来源
Bone Marrow Transplantation | 2016年 / 51卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1241 / 1244
页数:3
相关论文
共 50 条
  • [1] Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy
    Vasu, S.
    Wu, H.
    Satoskar, A.
    Puto, M.
    Roddy, J.
    Blum, W.
    Klisovic, R.
    Andritsos, L.
    Hofmeister, C.
    Benson, D. M.
    Efebera, Y.
    Jaglowski, S.
    Penza, S.
    Cohen, D.
    Devine, S.
    Cataland, S.
    BONE MARROW TRANSPLANTATION, 2016, 51 (09) : 1241 - 1244
  • [2] Eculizumab in Transplant-Associated Thrombotic Microangiopathy
    Dhakal, Prajwal
    Giri, Smith
    Pathak, Ranjan
    Bhatt, Vijaya Raj
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (02) : 175 - 180
  • [3] Eculizumab for transplant-associated thrombotic microangiopathy in adult allogeneic stem cell transplant recipients
    Rudoni, Joslyn
    Jan, Anna
    Hosing, Chitra
    Aung, Fleur
    Yeh, Jason
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 389 - 398
  • [4] Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
    Elsallabi, Osama
    Bhatt, Vijaya Raj
    Dhakal, Prajwal
    Foster, Kirk W.
    Tendulkar, Ketki K.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (01) : 12 - 20
  • [5] Treatment of Hematopoietic Stem Cell Transplant-Associated Microangiopathy with Eculizumab
    Akyol, Gulsah
    Unsal, Serife Emre
    Mandaci, Neslihan Sanli
    Keklik, Muzaffer
    Unal, Ali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S594 - S594
  • [6] Successful treatment of transplant-associated thrombotic microangiopathy with eculizumab
    Demircioglu, S.
    Dogan, A.
    Demir, C.
    LEUKEMIA RESEARCH, 2019, 85 : S58 - S58
  • [7] Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy
    Schoettler, Michelle L.
    Lehmann, Leslie
    Kao, Pei -Chi
    Chen, Nan
    Jodele, Sonata
    Chonat, Satheesh
    Williams, Kirsten M.
    London, Wendy B.
    Duncan, Christine
    Dandoy, Christopher
    BLOOD ADVANCES, 2024, 8 (05) : 1220 - 1233
  • [8] Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation
    Gavriilaki, Eleni
    Sakellari, Ioanna
    Batsis, Ioannis
    Mallouri, Despina
    Bousiou, Zoi
    Vardi, Anna
    Yannaki, Evangelia
    Constantinou, Varnavas
    Tsompanakou, Aliki
    Vadikoliou, Chrysanthi
    Kaloyannidis, Panayotis
    Bamihas, Gerasimos
    Anagnostopoulos, Achilles
    CLINICAL TRANSPLANTATION, 2018, 32 (09)
  • [9] Eculizumab to Treat Posterior Reversible Encephalopathy Syndrome Due to Underlying Transplant-Associated Thrombotic Microangiopathy in Patients Receiving Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease
    Bhunia, Nabanita
    Abu-Arja, Rolla
    Bajwa, Rajinder P. S.
    Auletta, Jeffery J.
    Rangarajan, Hemalatha G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [10] Eculizumab for the Treatment of Severe Transplant-associated Thrombotic Microangiopathy: Multicenter Experience
    Yehudai-Ofir, Dana
    Henig, Israel
    Frisch, Avraham
    Shimoni, Avichai
    Avni, Batia
    Grisariu, Sigal
    Ram, Ron
    Yeshurun, Moshe
    Zuckerman, Tsila
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 607 - 608